NEW: Pfizer-BioNTech says it has asked the FDA to authorize its Covid-19 vaccine in children ages 6 months to 4 years — the only group that remains ineligible for vaccination.
A health care worker administers a Pfizer-BioNTech Covid-19 vaccination to a child in San Francisco on Jan. 10, 2022.Berkeley Lovelace Jr.
Pfizer-BioNTech said Wednesday that it asked the Food and Drug Administration to authorize its Covid-19 vaccine for children ages 6 months to 4 years — the only group that remains ineligible for vaccination. The request will be now considered by the FDA, which will review the data and could grant emergency use authorization for the age group later this month.The FDA’s advisory group, called the Vaccines and Related Biological Products Advisory Committee, is scheduled to convene on June 15 to offer guidance on the pediatric doses.
The FDA could clear doses for the age group within days of a favorable recommendation from the committee. The Centers for Disease Control and Prevention will still need to sign off on the doses, as the agency has done for all other age groups. Wednesday's announcement may bring some relief to parents eagerly awaiting to vaccinate their littlest children.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer to exit GSK's consumer health arm after spin-offPfizer plans to exit its 32% stake in Haleon, its consumer health joint venture with British drugmaker GSK , after the business is spun off as an independent listed company in July, GSK said on Wednesday.
Read more »
Strawberries likely caused hepatitis A outbreak, FDA saysOrganic strawberries linked to hepatitis A outbreak were sold at many food stores. onyourside consumeralert alabamanewsnetwork
Read more »
FDA investigates hepatitis A outbreak in California linked to strawberriesOrganic strawberries branded FreshKampo or HEB may be linked to 17 cases nationwide, including 15 in California.
Read more »